about
Optimizing geometric accuracy of four-dimensional CT scans acquired using the wall- and couch-mounted Varian® Real-time Position Management™ camera systemsGeometrical analysis of radiotherapy target volume delineation: a systematic review of reported comparison methods.Intraoperative radiotherapy in early stage breast cancer: potential indications and evidence to date.Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study.The mediastinal staging accuracy of 18F-Fluorodeoxyglycose positron emission tomography/computed tomography in non-small cell lung cancer with variable time intervals to surgery.Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer.Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.Motion management for radical radiotherapy in non-small cell lung cancer.Stereotactic body radiotherapy for oligometastatic disease.PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.Immune modulation in advanced radiotherapies: Targeting out-of-field effects.The Impact of Colleague Peer Review on the Radiotherapy Treatment Planning Process in the Radical Treatment of Lung Cancer.Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy.FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung Cancer.A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer.Radiotherapy and Immunotherapy Combinations in Non-small Cell Lung Cancer: A Promising Future?The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer.UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy.18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist?(18)F-FDG PET-CT simulation for non-small-cell lung cancer: effect in patients already staged by PET-CT.Standardization of scanning for [18F]fluorodeoxyglucose positron emission tomography.The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung Cancer.Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol.Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits.Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cUK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy: Reply to Ghafoor et al.Predicting Outcomes From Radical Radiotherapy for Non-small Cell Lung Cancer: A Systematic Review of the Existing LiteratureDefining Target Volumes for Stereotactic Ablative Radiotherapy of Early-stage Lung Tumours: A Comparison of Three-dimensional 18F-fluorodeoxyglucose Positron Emission Tomography and Four-dimensional Computed TomographyTowards photon radiotherapy treatment planning with high Z nanoparticle radiosensitisation agents: the Relative Biological Effective Dose (RBED) frameworkA case of prolonged type 1 hypersensitivity reaction to pegfilgrastimRe: Stereotactic Body Radiotherapy for Oligometastatic DiseaseIn Regard to Vaidya et alPreoperative chemotherapy for non-small-cell lung cancerReferrals Patterns to an Oncology Clinical Advice ServiceDo protons have a role in the treatment of locally advanced NSCLC with radiotherapy?Thoracic intervention and surgery to cure lung cancer: an overview of stereotactic ablative radiotherapy in early and oligometastatic lung cancerAn overview on personalisation of radiotherapy prescriptions in locally advanced non-small cell lung cancer: Are we there yet?The Abscopal Effect of Stereotactic Radiotherapy and Immunotherapy: Fool's Gold or El Dorado?
P50
Q30392150-DC429698-56AA-4FA5-A575-1EDA4E709855Q33606505-1EFEE7CF-F20A-4CD6-BED7-3EAAF32CB117Q36235523-86D89461-1E62-4CD3-94DB-08D281477626Q36818897-8DE282A8-9C58-46F7-955D-BECF58B23795Q37131297-725741B3-442E-40FB-B841-204CFAFF4CA3Q37353925-83691331-C1EB-44C0-80D8-E98920E66C1EQ37767027-B4C66804-D92A-4754-A0BC-2F6DE9073CDFQ38167438-8CF657A0-4602-4087-A388-3BC3A0137826Q38377495-B809118D-0761-4802-8B09-1DEB1722B076Q38419113-40545D03-4CBE-4560-9FBC-A9E307F172D4Q38429240-46F6A166-B2E7-444B-83EC-0285EC5B9A51Q38543483-65B1D061-897D-4854-8491-EC4B8E50DEECQ38697545-2F0B7106-66FA-4BA9-A51B-57C69B474EE6Q38754740-CAF9A639-6D62-497D-8768-861BD08F0E48Q38790915-2BEA8104-D5EA-4EA2-B187-C5754A84CEE5Q38831848-229136BA-6C51-49EE-85E3-1C5DEE1C7648Q38945410-39F10AB3-5629-4DCC-ABEA-9EA39D7C1A23Q42697004-93A5C0F6-2A98-4B73-81B1-EC572E6E75D8Q43115647-83745920-F4D4-4ABE-8CB4-956EB3CFD672Q43295889-0B6F482A-9751-4356-B169-21132674D581Q46165932-83351AFB-7110-42D7-A9F0-6FC3CE262C2EQ47314874-2F3504E0-6D70-4A9E-8B65-C59D6018B681Q48763632-1EC268FA-0824-42A5-A25B-35D90A7CF879Q49976711-604EA860-CBC1-4D00-A72C-39D7F33FCBAEQ51133431-C9058C4A-4CC0-4C51-8F1A-A29A008399FAQ52579899-6E8D8E9B-1222-4BB9-86C7-8081F0AA1817Q52582229-903FCEEA-91C4-424E-AAAE-B983E7D0FD4FQ52801973-7E41FD98-8B7F-4520-BB72-97D7E6835A67Q58576082-912A12E1-748D-49EC-82A9-97CD842AE706Q59587390-D921DC9E-A2CE-4F1F-845F-8D368F2E96BAQ59793133-020298C8-CD2E-4FC7-BD73-23A063669862Q80722392-0E6198C7-09FD-4FBB-B1ED-C9D2CC231031Q85531728-348C24AF-37C8-4F20-8B5E-F6F36BFCF777Q85635193-12FEB979-A521-48CE-9BC8-9C40E1137DCCQ87416333-AB02D69B-C8AD-4E44-B61D-8A9CA74C537BQ88083181-C7D29247-6A0C-4A28-B728-8E27C5063298Q88332526-8400DE23-2E15-41A9-830A-1543F37A2FDCQ88407400-C159D63C-BDDC-4F41-BC29-0E538DC4EB7EQ89124987-50AF54F0-1F1B-4DEB-B2B5-0D7177A91F5CQ90039281-11DC3ED6-0543-4EF5-B802-7C9722FB54AD
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gerard G Hanna
@ast
Gerard G Hanna
@en
Gerard G Hanna
@es
Gerard G Hanna
@nl
Gerard G Hanna
@sl
type
label
Gerard G Hanna
@ast
Gerard G Hanna
@en
Gerard G Hanna
@es
Gerard G Hanna
@nl
Gerard G Hanna
@sl
altLabel
Gerry Hanna
@en
prefLabel
Gerard G Hanna
@ast
Gerard G Hanna
@en
Gerard G Hanna
@es
Gerard G Hanna
@nl
Gerard G Hanna
@sl
P106
P2038
Gerard_Hanna
P21
P2798
P31
P496
0000-0003-1003-5138